Asia Pacific In-Vitro Toxicology Testing Market Size & Outlook
The in-vitro toxicology testing market in Asia Pacific is expected to reach a projected revenue of US$ 8,513.8 million by 2030. A compound annual growth rate of 11% is expected of Asia Pacific in-vitro toxicology testing market from 2024 to 2030.
Every answer starts with GVR research, and every figure is cited.Explore Prism AI ↗
Asia Pacific in-vitro toxicology testing market highlights
The Asia Pacific in-vitro toxicology testing market generated a revenue of USD 4,096.8 million in 2023.
The market is expected to grow at a CAGR of 11% from 2024 to 2030.
In terms of segment, pharmaceutical industry was the largest revenue generating end user in 2023.
Diagnostics is the most lucrative end user segment registering the fastest growth during the forecast period.
Country-wise, India is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
Market revenue in 2023
USD 4,096.8 million
Market revenue in 2030
USD 8,513.8 million
Growth rate
11% (CAGR from 2023 to 2030)
Largest segment
Pharmaceutical industry
Fastest growing segment
Diagnostics
Historical data covered
2018 - 2022
Base year for estimation
2023
Forecast period covered
2024 - 2030
Quantitative units
Revenue in USD million
Market segmentation
Pharmaceutical Industry, Cosmetics And Household Products, Academic Institutes and Research Laboratories, Diagnostics, Chemicals Industry, Food Industry
Key market players worldwide
Charles River Laboratories International Inc, SGS, Merck KGaA, Eurofins Scientific SE, Abbott Laboratories, Labcorp Holdings Inc, Evotec SE, Thermo Fisher Scientific Inc, Quest Diagnostics Inc, Agilent Technologies Inc, Catalent Inc, Danaher Corp, Bio-Rad Laboratories Inc
Other key industry trends
In terms of revenue, Asia Pacific region accounted for 13.2% of the global in-vitro toxicology testing market in 2023.
Globally, North America is projected to lead the regional market in terms of revenue in 2030.
North America is the fastest growing regional market and is projected to reach USD 32,265.4 million by 2030.
Asia Pacific market is expected to grow at the fastest CAGR during the forecast period. The overall regional growth can be attributed to countries such as China, India, and South Korea. China In vitro toxicology testing market is estimated to be the largest revenue-generating market, while India is projected to witness the fastest growth rate.
The launch of a substantial number of initiatives across the region is anticipated to positively impact the entities involved in toxicology testing. One such entity that is likely to be benefitted is the Singapore-based TÜV SÜD PSB, which offers testing and product certification services including in vitro toxicology services.
Asia Pacific In-vitro Toxicology Testing Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to In-vitro Toxicology Testing Market Outlook will help companies and investors design strategic landscapes.
Pharmaceutical Industry was the largest segment with a revenue share of 43.36% in 2023.
Horizon Databook has segmented the Asia Pacific in-vitro toxicology testing market based on pharmaceutical industry, cosmetics and household products, academic institutes and research laboratories, diagnostics, chemicals industry, food industry covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific market is expected to grow at the fastest CAGR during the forecast period. The overall regional growth can be attributed to countries such as China, India, and South Korea. China In vitro toxicology testing market is estimated to be the largest revenue-generating market, while India is projected to witness the fastest growth rate.
The launch of a substantial number of initiatives across the region is anticipated to positively impact the entities involved in toxicology testing. One such entity that is likely to be benefitted is the Singapore-based TÜV SÜD PSB, which offers testing and product certification services including in vitro toxicology services.
Asia Pacific In-Vitro Toxicology Testing Market End User Outlook (Revenue, USD Million , 2018-2030)
Pharmaceutical Industry
Cosmetics And Household Products
Academic Institutes and Research Laboratories
Diagnostics
Chemicals Industry
Food Industry
Asia Pacific In-Vitro Toxicology Testing Market Technology Outlook (Revenue, USD Million , 2018-2030)
Cell Culture Tech
High Throughput Tech
Molecular Imaging
OMICS Tech
Asia Pacific In-Vitro Toxicology Testing Market Product Outlook (Revenue, USD Million , 2018-2030)
Consumables
Assays
Instruments
Software
Services
Asia Pacific In-Vitro Toxicology Testing Market Application Outlook (Revenue, USD Million , 2018-2030)
Systemic Toxicology
Dermal Toxicity
Endorine Disruption
Occular Toxicity
Others
Asia Pacific In-Vitro Toxicology Testing Market Method Outlook (Revenue, USD Million , 2018-2030)
Cellular Assay
Biochemical Assay
In Silica
Ex-vivo
Reasons to subscribe to In-vitro Toxicology Testing Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of In-vitro Toxicology Testing Market Outlook databook
Our clientele includes a mix of In-vitro Toxicology Testing Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific In-vitro Toxicology Testing Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific In-vitro Toxicology Testing Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Asia Pacific In-Vitro Toxicology Testing Market, 2018-2030 (US$M)